Clinical Trial Update: Study to Assess the Safety, Tolerability, PK and PD of ABX1100 [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of ABX1100 in healthy volunteers and in individuals with Late-Onset Po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Pompe Disease

Drugs mentioned

• ABX1100 (ABX1100)

Snippet

Sponsor: Aro Biotherapeutics | Conditions: Healthy, Late Onset Pompe Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING